Addus HomeCare (NASDAQ:ADUS) Downgraded by Barclays

Addus HomeCare (NASDAQ:ADUS) was downgraded by equities researchers at Barclays from an “equal weight” rating to an “underweight” rating in a report released on Tuesday, Marketbeat reports. They presently have a $83.00 price target on the stock. Barclays‘s price target would suggest a potential downside of 11.22% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the stock. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Royal Bank of Canada reissued an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $118.00 target price on shares of Addus HomeCare in a research note on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $103.00.

Addus HomeCare Stock Down 3.8 %

NASDAQ ADUS opened at $93.49 on Tuesday. The company’s 50 day simple moving average is $97.58 and its 200 day simple moving average is $91.48. The company has a market capitalization of $1.52 billion, a P/E ratio of 24.35, a PEG ratio of 1.92 and a beta of 0.95. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. Addus HomeCare has a 12 month low of $77.30 and a 12 month high of $114.97.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, February 26th. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The company had revenue of $276.35 million during the quarter, compared to the consensus estimate of $274.02 million. Equities research analysts expect that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in ADUS. Mesirow Financial Investment Management Inc. acquired a new position in Addus HomeCare in the first quarter valued at approximately $234,000. Chatham Capital Group Inc. boosted its stake in shares of Addus HomeCare by 15.1% in the 1st quarter. Chatham Capital Group Inc. now owns 21,344 shares of the company’s stock worth $2,206,000 after buying an additional 2,795 shares during the last quarter. Guidance Capital Inc. boosted its stake in shares of Addus HomeCare by 71.6% in the 1st quarter. Guidance Capital Inc. now owns 4,783 shares of the company’s stock worth $463,000 after buying an additional 1,996 shares during the last quarter. Bridge City Capital LLC raised its holdings in shares of Addus HomeCare by 46.4% in the 1st quarter. Bridge City Capital LLC now owns 30,999 shares of the company’s stock worth $3,203,000 after purchasing an additional 9,819 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Addus HomeCare by 40.8% during the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the period. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.